Empresaria Group plc provided earnings guidance for the year ended December 31, 2015. For the year, the company expects adjusted profit before tax growth of approximately 23% year on year, with net fee income approximately 10% ahead of the prior year. Total net debt is expected to reduce by 26% from £9.8 million in 2014 to £7.3 million in 2015, which includes the term loan, as announced in October 2015, to help fund the acquisition of Pharmaceutical Strategies in the USA.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.5 GBX | 0.00% | 0.00% | +19.12% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+19.12% | 25.28M | |
+37.58% | 79.51B | |
+5.01% | 45.16B | |
-12.76% | 5.2B | |
-29.84% | 1.75B | |
+8.38% | 1.49B | |
+0.52% | 1.4B | |
-30.28% | 1.1B | |
-19.88% | 1.06B | |
+16.81% | 876M |
- Stock Market
- Equities
- EMR Stock
- News Empresaria Group plc
- Mpresaria Group plc Provides Earnings Guidance for the Year Ended December 31, 2015